Navigation Links
Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds

SUNNYVALE, Calif., April 11, 2007 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. announced today multiple presentations regarding its novel histone deacetylase (HDAC) inhibitor and Bruton's tyrosine kinase inhibitor compounds. The presentations will take place at the American Association for Cancer Research (AACR) 2007 Annual Meeting being held April 14-18, 2007, at the Los Angeles Convention Center, in Los Angeles, CA.

    The presentations are as follows:


    Sunday, April 15, 2007

    Session: HDAC Inhibitors 1

    Poster Presentation: Mechanisms of sensitivity in primary hematopoietic

    tumors and tumor lines to a novel HDAC inhibitor PCI-24781

    Abstract #678:  8:00 a.m. -12:00 p.m.

    Presenter:  Sriram Balasubramanian, Ph.D., Pharmacyclics, Inc.


    Session: HDAC Inhibitors 1

    Poster Presentation: Radiosensitization by the HDAC inhibitor PCI-24781 in

    SiHa and WiDr human tumor cell lines

    Abstract #695:  8:00 a.m. -12:00 p.m.

    Presenter:  Peggy L. Olive, Ph.D., British Columbia Cancer Research Center


    Monday, April 16, 2007

    Session: Targeted Agents and Other Novel Therapies

    Poster Presentation: Identification of cross-validated functional

    biomarkers for a novel HDAC inhibitor PCI-24781, and their utility for

    selection of clinical indications

    Abstract #1830:  8:00 a.m. -12:00 p.m.

    Presenter:  Sriram Balasubramanian, Ph.D., Pharmacyclics, Inc.


    Session: DNA Repair and Chemotherapeutic Agent Resistance

    Poster Presentation: Novel histone deacetylase (HDAC) inhibitor PCI-24781

    disrupts RAD51 foci and inhibits homologous recombination

    Abstract #1966:  8:00 a.m. -12:00 p.m.

    Presenter:  Shanthi Adimoolam, Ph.D., Pharmacyclics, Inc.


    Wednesday, April 18, 2007

    Session: Kinases 1

    Poster Presentation: PCI-31523: An irreversible inhibitor of Bruton's

    tyrosine kinase (Btk) that disrupts B cell receptor (BCR) signaling, is

    cytotoxic to B cell lympho
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
3. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
4. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... Calif. , Oct 22, 2014 Antigen ... Irvine, California , announced the receipt of ... Business Innovation Research award (SBIR) from the National Institute of Dental ... fund the development of a Pan-HIV Protein Microarray Chip, ... HIV-1 and HIV-2 subtypes and aid in the development ...
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive Medicine ... leader in the field of infertility, presents new ... embryonic screening. The research abstract, released during the ... Medicine (ASRM) meeting in Honolulu, Hawaii ... single gene defect (SGD) pre-implantation genetic diagnosis (PGD). ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3
(Date:10/25/2014)... Randy Dotinga HealthDay Reporter ... genetic tests are developed that spot increased risks for certain ... proactive about getting screened. But a new study suggests ... behavior: People who found out their genes doubled their risk ... average risk to get screened. "It didn,t make any ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
(Date:10/22/2014)... 2014 Isabel Healthcare will ... Professions (ASAHP) Conference on October 22-24 in Las Vegas, ... in a panel discussion on Technology in Health Professions ... provides a diagnostic decision support tool and clinical education ... of students and clinical learners. The Isabel tools help ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- The ... passengers arriving from Ebola-affected nations of West Africa ... screen them for infection with the virus. ... Jeh Johnson noted that 94 percent of air ... land at one of these five airports -- ...
(Date:10/22/2014)... California (PRWEB) October 22, 2014 Hay House ... Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) written ... of Yoga & Recovery. This book is meant to ... in a life of recovery. , Recovery 2.0 is ... 12 Steps; Recovery 2.0 is a guide for what comes ...
Breaking Medicine News(10 mins):Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
... ... your brand, advertising campaign, competitors or product innovations. , ... (PRWEB) April 6, 2010 -- Six Degrees has ... affordable way to gather insights needed to optimize marketing strategies, increase advertising effectiveness, gather ...
... is weak , TUESDAY, April 6 (HealthDay News) -- A ... in fruits and vegetables helps protect against cancer. , U.S. ... in 10 European countries and found only a weak association ... risk. , The study did find that heavy drinkers who ...
... ARBOR, Mich.---The proportion of older middle-aged Americans who report ... 2007, in contrast to the disability decline that has ... to a new study by the RAND Corporation and ... in the proportion of Americans aged 50 to 64 ...
... support care between office visits, boost efficiency and convenience, ... the April Health Affairs suggests how to ... patients how they like it and what they want. ... health information technology they use is meeting their needs ...
... ... Builders of the Dawn reveals a new world growing all around us and the keys to ... ... planet in 2010 may make some people want to go into hiding. But the authors of ...
... 5, 2010 The Clinical Practice Model Resource Center ... practice guidelines for healthcare, today launched its first Web-based ... online edition of its award-winning guidelines supports new and ... collaboration with a model that helps improve practice at ...
Cached Medicine News:Health News:Fruits, Veggies Have Modest Effect on Cancer Risk 2Health News:Middle-aged Americans report more mobility-related disabilities 2Health News:Middle-aged Americans report more mobility-related disabilities 3Health News:Want better health information technology? Ask patients how they want it 2Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 2Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 3Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 4Health News:The Practical Visionary Offers Eight Keys to Surviving and Thriving in the 21st Century, 5Health News:The CPM Resource Center launches Web-based clinical practice guidelines 2
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
Leg holder for arthroscopy....
Irrigation pump for arthroscopy....
The 300 watt Xenon light source will provide intense illumination necessary for demanding, advanced endoscopic procedures....
Medicine Products: